Variants in SCN1A are associated with a spectrum of disorders in which the seizure phenotype is variable, from simple, self-remitting febrile seizures at the mild end, to drug-resistant epilepsy in people with Dravet syndrome at the severe end. Here, SCN1A is linked to encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.